Showing results (321-330 of 390) with videos related to

Sort By:
Pageof 39
The Lancet. Neurology|April 17, 2007
Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoringLudwig Kappos, David Bates, Hans-Peter Hartung, et al.
Medrxiv : the Preprint Server for Health Sciences|July 23, 2024
Long COVID Brain Fog Treatment: Findings from a Pilot Randomized Controlled Trial of Constraint-Induced Cognitive TherapyGitendra Uswatte, Edward Taub, Karlene Ball, et al.
Rehabilitation Psychology|May 1, 2025
Long COVID brain fog treatment: An early-phase randomized controlled trial of constraint-induced cognitive therapy signals goGitendra Uswatte, Edward Taub, Karlene Ball, et al.
Neurology|October 24, 2019
Evaluation of multiple sclerosis disability outcome measures using pooled clinical trial dataMyla D Goldman, Nicholas G LaRocca, Richard A Rudick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 19, 2019
Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular SchwannomaScott R Plotkin, Dan G Duda, Alona Muzikansky, et al.
Muscle & Nerve|June 5, 2025
MGBase: A Global, Observational Registry for Collaborative Research in Myasthenia GravisKatherine A Buzzard, Anneke Van der Walt, Helmut Butzkueven, et al.
Journal of Clinical Medicine|February 26, 2025
Influence of Baseline Kidney Function on Patient and Kidney Outcomes in Patients with COVID-19: A Multi-National Observational StudyHarin Rhee, Etienne Macedo, Gary Cutter, et al.
Pageof 39